Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.

MLA

Sellamuthu, Satheeshkumar, et al. “Type-II NADH Dehydrogenase (NDH-2): A Promising Therapeutic Target for Antitubercular and Antibacterial Drug Discovery.” Expert Opinion on Therapeutic Targets, vol. 21, no. 6, June 2017, pp. 559–70. EBSCOhost, https://doi.org/10.1080/14728222.2017.1327577.

APA

Sellamuthu, S., Singh, M., Kumar, A., & Singh, S. K. (2017). Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery. Expert Opinion on Therapeutic Targets, 21(6), 559–570. https://doi.org/10.1080/14728222.2017.1327577

Chicago

Sellamuthu, Satheeshkumar, Meenakshi Singh, Ashok Kumar, and Sushil Kumar Singh. 2017. “Type-II NADH Dehydrogenase (NDH-2): A Promising Therapeutic Target for Antitubercular and Antibacterial Drug Discovery.” Expert Opinion on Therapeutic Targets 21 (6): 559–70. doi:10.1080/14728222.2017.1327577.